Obesity
Filter News
Found 1 articles
-
Keros Therapeutics to Develop KER-065 for the Treatment of Obesity
1/3/2024
Keros Therapeutics, Inc. today announced that it plans to develop KER-065, a novel ligand trap designed to bind to and inhibit TGF-ß ligands, including myostatin (GDF8) and activin A, for the treatment of obesity.